. 2019 Oct 23;9:15234. doi: 10.1038/s41598-019-51675-y

Table 2.

Relationship between preoperative PDW and clinical-pathological features in patients with ESCC.

Characteristics	Total patients	PDW <13.4 (n = 254)	PDW ≥13.4 (n = 241)	P value
Sex	Male	219	209	0.870
Sex	Female	35	32	0.870
Age at therapy initiation(years)	≤60	112	117	0.321
Age at therapy initiation(years)	>60	142	124	0.321
Pathology grade	Well differentiated	22	16	0.390
	middle differentiated	170	156
	Poorly differentiated	56	65
	Undifferentiated	0	1
Depth of tumor	T1a–1b	34	17	0.031
	T2	44	56
	T3	176	168
Lymph node metastasis	N0	123	108	0.260
	N1	89	76
	N2	32	42
	N3	10	15
Pathological stage	1a–1b	49	42	0.844
	2a–2b	93	88
	3a–3c	112	111
Vessel invasive	Yes	63	75	0.117
Vessel invasive	No	191	166	0.117
Nerve infiltration	Yes	74	95	0.016
Nerve infiltration	No	180	146	0.016
Treatment regimen	S	163	176	0.102
	S plus postoperative C	64	47
	S plus postoperative CRT	27	18
Hospital time after operation(days)	≤14	215	184	0.020
Hospital time after operation(days)	>14	39	57	0.020
Platelet	Median	222.0	171.0	<0.001
Platelet	Interquartile range	(190.0–257.0)	(142.0–206.0)	<0.001
Albumin	Median	42.1	41.9	0.992
Albumin	Interquartile range	(39.7–44.1)	(39.3–44.4)	0.992
RDW	Median	12.7	12.9	<0.001
RDW	Interquartile range	(12.3–13.2)	(12.4–13.4)	<0.001
Aspartate transaminase	Median	21.0	23.0	0.001
Aspartate transaminase	Interquartile range	(19.0–26.0)	(19.0–29.0)	0.001
Fibrinogen	Median	3.8	3.7	0.108
Fibrinogen	Interquartile range	(3.3–4.4)	(3.1–4.3)	0.108
Hemoglobin	Median	13.8	13.7	0.169
Hemoglobin	Interquartile range	(12.8–14.7)	(12.6–14.5)	0.169

Abbreviations: S, surgery; C, chemotherapy; CRT, chemoradiotherapy; PDW, platelet distribution width; RDW, red cell distribution width.